Back to Feed
ClinicalTrials.gov|Clinical Trial
Individual Molecular MRD Monitoring for MDS Patients After Allo-SCT
Nordic MDS Group
Abstract
This study aims to develop highly sensitive methods for early detection of relapse based on the patients unique mutations. Initially, a mutational screen is being performed. Primers directed against these mutations will be constructed and presence of mutations will be followed in bone marrow and blood frequently after transplantation. Status: COMPLETED Conditions: MDS; SCT; MRD
Keywords
MDSSCTMRD